Bath & Body Works, Inc. BBWI
18.66 USD -0.05 (-0.27%)
Regular-session close
18.80 +0.14 +0.75%
After hours · Nov 20, 6:53 PM ET
18.29 Day range 19.33
14.28 52-week range 24.94
- YTD
- -7.07%
- 1 year
- +17.95%
Benzinga news
benzinga.com UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $19 UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $22 to $19.
benzinga.com JP Morgan Maintains Neutral on Bath & Body Works, Lowers Price Target to $23 JP Morgan analyst Matthew Boss maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $24 to $23.
benzinga.com B of A Securities Maintains Buy on Bath & Body Works, Lowers Price Target to $25 B of A Securities analyst Lorraine Hutchinson maintains Bath & Body Works (NYSE:BBWI) with a Buy and lowers the price target from $30 to $25.
benzinga.com Bath & Body Works Analysts Slash Their Forecasts After Q3 Earnings Bath & Body Works beat Q3 estimates and raised FY26 sales outlook, but cut GAAP EPS guidance and gave weak Q4 forecasts; analysts lowered price targets.benzinga.com BMO Capital Maintains Market Perform on Bath & Body Works, Lowers Price Target to $20 BMO Capital analyst Kelly Crago maintains Bath & Body Works (NYSE:BBWI) with a Market Perform and lowers the price target from $24 to $20.
benzinga.com Wells Fargo Maintains Overweight on Bath & Body Works, Lowers Price Target to $24 Wells Fargo analyst Ike Boruchow maintains Bath & Body Works (NYSE:BBWI) with a Overweight and lowers the price target from $25 to $24.
benzinga.com Morgan Stanley Maintains Equal-Weight on Bath & Body Works, Lowers Price Target to $21 Morgan Stanley analyst Alex Straton maintains Bath & Body Works (NYSE:BBWI) with a Equal-Weight and lowers the price target from $22 to $21.
benzinga.com Baird Maintains Neutral on Bath & Body Works, Lowers Price Target to $22 Baird analyst Mark Altschwager maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $23 to $22.
benzinga.com Bath & Body Works Shares Rise Despite Weak Holiday Outlook as Q3 Earnings Beat Estimates Bath & Body Works beat Q3 estimates and raised 2026 sales outlook, but cautious Q4 guidance and weaker store sales pressured shares.benzinga.com Bath & Body Works Affirms Q4 GAAP EPS Guidance of $1.41-$1.61 vs $1.71 Est; Sees Sales $2.574B-$2.670B vs $2.666B Est Bath & Body Works (NYSE:BBWI) affirms Q4 GAAP EPS guidance from $1.41-$1.61 to $1.41-$1.61 vs $1.71 analyst estimate. sees sales of $2.574 billion-$2.670 billion vs $2.666 billion analyst estimate.
benzinga.com Bath & Body Works Q3 Adj. EPS $0.26 Beats $0.12 Estimate, Sales $1.577B Beat $1.551B Estimate Bath & Body Works (NYSE:BBWI) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.12 by 116.67 percent. This is a 25.71 percent decrease over earnings of…
benzinga.com Bath & Body Works Lowers FY2026 GAAP EPS Guidance from $3.13-$3.33 to $3.09-$3.29 vs $2.96 Est Bath & Body Works (NYSE:BBWI) lowers FY2026 GAAP EPS guidance from $3.13-$3.33 to $3.09-$3.29 vs $2.96 analyst estimate..
benzinga.com Bath & Body Works Affirms FY2026 Adj EPS Guidance of $2.60-$2.80 vs $2.74 Est; Raises FY2026 Sales Guidance from $6.999B-$7.109B to $7.043B-$7.138B vs $7.105B Est Bath & Body Works (NYSE:BBWI) affirms FY2026 Adj EPS guidance from $2.60-$2.80 to $2.60-$2.80 vs $2.74 analyst estimate. Raises FY2026 sales outlook from $6.999 billion-$7.109 billion to $7.043…
benzinga.com UBS Maintains Neutral on Bath & Body Works, Raises Price Target to $22 UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and raises the price target from $17 to $22.
benzinga.com Wells Fargo Maintains Overweight on Bath & Body Works, Raises Price Target to $25 Wells Fargo analyst Ike Boruchow maintains Bath & Body Works (NYSE:BBWI) with a Overweight and raises the price target from $24 to $25.
